Anterix Inc. (NASDAQ:ATEX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five brokerages that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $120.00.
ATEX has been the topic of a number of analyst reports. Clear Str raised shares of Anterix to a “strong-buy” rating in a report on Monday, July 27th. Weiss Ratings upgraded shares of Anterix from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Wall Street Zen downgraded shares of Anterix from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. DA Davidson set a $161.00 target price on shares of Anterix in a research note on Friday, August 21st. Finally, JPMorgan Chase & Co. reduced their target price on shares of Anterix from $133.00 to $130.00 and set an “overweight” rating for the company in a research note on Thursday, August 13th.
Get Our Latest Report on Anterix
Insider Buying and Selling
In other news, insider Gena L. Ashe sold 4,357 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $85.44, for a total transaction of $372,262.08. Following the completion of the transaction, the insider directly owned 5,174 shares in the company, valued at approximately $442,066.56. The trade was a 45.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Leslie B. Daniels sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $83.83, for a total value of $209,575.00. Following the transaction, the director owned 43,477 shares of the company’s stock, valued at approximately $3,644,676.91. This represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 124,841 shares of company stock valued at $10,975,765 in the last ninety days. Insiders own 40.05% of the company’s stock.
Institutional Trading of Anterix
Several large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new position in shares of Anterix in the second quarter worth $110,672,000. Jupiter Topco LLC acquired a new position in shares of Anterix during the second quarter valued at $68,189,000. Gamco Investors INC. ET AL increased its holdings in shares of Anterix by 0.8% during the first quarter. Gamco Investors INC. ET AL now owns 425,820 shares of the company’s stock valued at $16,262,000 after purchasing an additional 3,350 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Anterix by 30.8% during the first quarter. Dimensional Fund Advisors LP now owns 424,856 shares of the company’s stock valued at $16,223,000 after purchasing an additional 99,933 shares during the period. Finally, AYAL Capital Advisors Ltd raised its stake in shares of Anterix by 26.8% during the fourth quarter. AYAL Capital Advisors Ltd now owns 265,000 shares of the company’s stock valued at $5,785,000 after purchasing an additional 56,029 shares in the last quarter. 87.67% of the stock is currently owned by institutional investors and hedge funds.
Anterix Stock Performance
Shares of ATEX opened at $77.87 on Tuesday. Anterix has a 12 month low of $17.58 and a 12 month high of $113.00. The stock has a fifty day moving average price of $85.04 and a 200 day moving average price of $76.61.
Anterix (NASDAQ:ATEX – Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.44. Anterix had a negative return on equity of 10.65% and a net margin of 933.03%. The company had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $2.00 million. On average, equities analysts forecast that Anterix will post -2.00 EPS for the current fiscal year.
Anterix Company Profile
Anterix Inc (NASDAQ: ATEX) develops and enables private wireless broadband networks for critical infrastructure organizations in the United States. The company focuses on using its licensed 900 MHz spectrum to support secure, reliable communications for electric utilities and other organizations that require resilient connectivity for operational technology and field personnel.
Anterix provides spectrum access and related solutions designed to help utilities modernize communications networks, including support for grid management, outage response, remote monitoring, automation and other mission-critical applications.
See Also
- Five stocks we like better than Anterix
- 4 Stocks With Demand So Sticky That the AI Sell-Off Barely Touched Them at All
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
- Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.
